Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

Amgen (AMGN) agreed to acquire Horizon Therapeutics (HZNP) for $116.50 per share in cash [more]
Coupa Software (COUP) will be acquired by Thoma Bravo for $81 per share in cash [more]
Weber (WEBR) will be taken private by BDT Capital in an $8.05 per share transaction [more]
Rivian Automotive (RIVN) paused plans to produce electric commercial vans in Europe [more]
Inotiv (NOTV) said that Q1 earnings and liquidity could be impacted by Cambodian NHPs [more]

2. WALL STREET CALLS:

Micron (MU) downgraded to Hold from Buy at Deutsche Bank [more]
Under Armour (UAA) upgraded to Buy from Hold at Stifel [more]
Qualcomm (QCOM) downgraded to Underweight from Equal Weight at Wells Fargo [more]
Accenture (ACN) downgraded to Underweight from Neutral at Piper Sandler [more]
Gap (GSP) and Tapestry (TPR) were upgraded to Buy at Goldman Sachs, while Levi Strauss (LEVI) was downgraded to Neutral and RH (RH) downgraded to Sell at the firm [more]

3. AROUND THE WEB:

Coinbase (COIN) CEO Brian Armstrong believes regulation will boost USD Coin use, WSJ reports [more]
Samsung (SSNLF) will maintain memory output ramp-up, DigiTimes reports [more]
Credit Suisse (CS) accepted "suspicious" invoices for Greensill loan, FT reports [more]
FTC tussle with Microsoft (MSFT) puts a spotlight on cloud gaming, WSJ says [more]
Amid cheaper tech stocks, IAC (IAC) may actually be cheap enough, Barron's says [more]

4. MOVERS:

Meridian Bioscience (VIVO) higher after announcing the anticipated closing date of its pending merger [more]
Box (BOX) gains after JPMorgan upgraded the stock to Overweight with a price target of $34, up from $31 [more]
Adicet Bio (ACET) lower after reporting data from its ongoing ADI-001 Phase 1 trial [more]
Karyopharm Therapeutics (KPTI) declines after reporting updated results from its Phase 1 trial evaluating selinexor [more]
Fate Therapeutics (FATE) falls after it and GT Biopharma (GTBP) presented preclinical data on its dual antigen targeting approach [more]

5. EARNINGS/GUIDANCE:

Whole Earth Brands (FREE) reaffirms 2022 guidance [more]
Universal Technical (UTI) reported downbeat Q4 results [more]
Dynagas LNG (DLNG) reported a year-over-year decline in Q3 earnings and revenue [more]
Pembina Pipeline (PBA) provided FY23 adjusted EBITDA guidance [more]
Virco (VIRC) reported upbeat Q3 results [more]

INDEXES:

Near midday, the Dow was up 261.97, or 0.78%, to 33,738.43, the Nasdaq was up 29.33, or 0.27%, to 11,033.94, and the S&P 500 was up 18.49, or 0.47%, to 3,952.87.